Injection
Sermorelin Injection
A growth hormone-releasing peptide that supports deeper sleep, faster recovery and lean muscle by working with your body's own rhythm.
Starting at $179/mo
RecoverySkin & tissue
BPC-157 / TB-500 / GHK-Cu
RxPrescription onlyInjected under the skin · 5 days a week · 0.6 mg · Recovery · Skin & tissue
Starting at $229/mo
BPC-157 and TB-500 for recovery, plus GHK-Cu, a copper peptide studied for skin and tissue repair.
Choose your plan
Real prices from our pharmacy. Longer plans cost less per month and are billed up front. Pause or cancel anytime.
- Recovery pair plus a copper peptide for tissue and skin
- GHK-Cu is studied for collagen and wound repair
- One daily injection, dosed by your physician
Every plan includes
- Personalized, physician-guided plan
- Monthly, 3-month and 6-month plans
- Dispensed by a US-licensed compounding pharmacy
- Unlimited protocol adjustments and messaging
- Ongoing support and check-ins
- Pause or cancel anytime
- Reviewed by our in-house physicians
- Physician-guided care
- Ongoing, expert support
- 100% online
- Free, discreet shipping
What is BPC-157 / TB-500 / GHK-Cu?
(recovery blend with a copper peptide)
The BPC-157 and TB-500 recovery pair with GHK-Cu, a naturally occurring copper-binding peptide whose blood levels fall with age. GHK-Cu is studied for collagen production, wound repair and skin quality, which makes this the blend for recovery goals that include skin and connective tissue.
- How it is taken
- Injected under the skin
- How often
- 5 days a week
- Dose range
- 0.6 mg
- Form
- Recovery · Skin & tissue
3-in-1
BPC-157, TB-500 and GHK-Cu in a single daily injection
Each component has preclinical (and, for GHK-Cu, some human topical) evidence; the blend itself has not been studied in human trials. Prescribed off-label at your physician's discretion.
How it works,
week by week.
Day 1
A US-licensed physician reviews your injury or goal and your history and sets the dose. The kit includes everything you need.
Week 1
One small subcutaneous injection a day, usually near the area you are treating or in the abdomen. Most people find the routine easy within days.
Week 2–4
Repair signaling builds. Many people report less soreness and easier movement first; structural healing takes longer.
2–3 Months
A typical protocol runs 4 to 12 weeks. Your physician checks progress and decides whether to continue, pause or adjust.
Beyond
Peptides support recovery; load management, sleep and nutrition do the rest. Your physician helps you plan the next block if you need one.
What you may notice,
and when.
Faster recovery
less downtime between hard sessions
Tendons and joints
the most common reason members start
Gut comfort
reported most with the KPV and BPC-157 blends
Skin and tissue
reported most with the GHK-Cu blends
Individual results vary. Benefits reflect what Zepym Health members commonly report to their physician at check-ins; they are not the results of a clinical trial.
Safety first:
what to know before you start.
Important safety information and common side effects
Recovery peptides are generally well tolerated. The most common effects are mild: redness, itching or a small bump at the injection site, headache, flushing or nausea in the first days. Because these peptides support cell growth and blood-vessel formation, they are not prescribed with an active cancer, a cancer under evaluation, or during pregnancy or breastfeeding. GHK-Cu contains copper: tell your physician about Wilson's disease or copper sensitivity. Stop and seek care for hives, swelling of the face or lips or trouble breathing. Tell your physician about every medication you take.
The research behind
BPC-157.
A 15-amino-acid peptide from a gastric protein. Almost all of the evidence is from rodent and other animal studies; human data are a handful of small, uncontrolled reports.
About the added ingredient: TB-500 is a fragment of thymosin beta-4. Its human data are extremely limited; most of the published work is in animals, not controlled human trials.
- Human studies3 pilot studies
A 2025 review found only three human pilot studies: intra-articular knee pain, interstitial cystitis and an intravenous safety study. None is a controlled trial of tendon, muscle or bone healing.
Review of BPC-157 for musculoskeletal healing, PMC 2025 - Intravenous safety2 participants
A pilot study gave two healthy adults infusions of up to 20 mg. No measurable change in heart, liver, kidney, thyroid or glucose markers was seen, and no side effects were reported. Two people cannot establish safety.
Safety of intravenous infusion of BPC157 in humans: a pilot study, Europe PMC - Animal dataanimal data only
Rodent and other animal studies of tendon transection, muscle crush and bone fracture report faster healing. Most of this work comes from one research group in Croatia.
Review of BPC-157 for musculoskeletal healing, PMC 2025
What the studies found
- No benefit has been shown in people. Animal studies of tendon cuts, muscle crush and bone fracture report faster healing (review, PMC 2025).
- The only human data are three pilot studies without a controlled efficacy outcome, so no human benefit is established (review, PMC 2025).
- Cell and animal work reports protective effects on the stomach lining, gut and blood vessels after injury; these are unproven in people (2026 review of BPC-157).
No published human study has measured how BPC-157 behaves in people at the doses sold here. Research-grade and compounded versions were not the ones studied in animals or in the few human reports.
What this does not say
- No controlled human trial shows that BPC-157 heals tendons, muscles, bone or gut tissue.
- FDA's list of bulk drug substances that may present significant safety risks describes compounded BPC-157 as carrying immunogenicity risk, with limited safety data for the proposed routes. The entry is among withdrawn nominations and the compounding rules have changed, so check the FDA page before relying on it.
- The brand products are not the compounded versions described by FDA and the reviews. Oral capsules were not studied in people.
The research
behind it.
GHK-Cu stimulates collagen and elastin synthesis and supports wound repair in laboratory and topical studies; its levels in blood decline markedly with age.
BPC-157 and TB-500 bring the tendon, muscle and gut repair evidence. Your physician decides whether the added GHK-Cu fits your goals.
Getting started
takes a few minutes.
- 1
Connect with a physician
Answer a few questions online and a US-licensed physician reviews your health, history and goals to make sure treatment is right for you. 100% online. No in-person visit required.
- 2
Get your discreet shipment
If approved, your treatment is compounded by a US-licensed, LegitScript-certified pharmacy, inspected for quality, and shipped discreetly to your door.
- 3
Receive continuous support
Start with one goal, then keep building over time. Unlimited physician messaging, easy refills and dose adjustments, all from the Zepym Health app.
Frequently asked questions
Contact supportHow do I use BPC-157 / TB-500 / GHK-Cu?
Injected under the skin, 5 days a week, in the morning. The starting prescription is 20 units (0.6 mg) each time. Your physician sets your own dose and it is printed on your label.
What exactly is in it?
BPC-157, TB-500, GHK-Cu.
How much arrives in each shipment?
1 vial at the starting strength, shipped to your door from a licensed US pharmacy.
What does GHK-Cu add?
A copper peptide studied for collagen production, wound repair and skin quality. It is added when recovery goals include skin, connective tissue or healthy aging. Your physician decides whether it is right for you; tell them about any copper sensitivity or Wilson's disease.
How do I take it?
A small subcutaneous injection once a day with an insulin-style needle, usually in the abdomen or near the area you are treating. Your physician sets the dose and the length of the protocol; the kit includes everything.
What are the side effects?
Mild and local for most people: redness, itching or a small bump where you inject, and occasionally headache, flushing or nausea in the first days. These peptides are not prescribed with an active or suspected cancer or in pregnancy. Read the safety information above.
How strong is the evidence?
Honest answer: early. There is decades of preclinical research and clinical experience, but few controlled human trials. Your physician explains that before prescribing, and these peptides are prescribed off-label at their discretion.
BPC-157 / TB-500 / GHK-Cu educational content reviewed by our physician
Scott Nass, MD Doctor of Medicine, board-certified in Family Medicine
Charles R. Drew University and David Geffen School of Medicine at UCLA. Family Medicine residency at Ventura County Medical Center.
More options
in this area.
Injection
Tesamorelin
A peptide that targets stubborn abdominal fat and supports a leaner body composition, prescribed and monitored by a licensed clinician.
Starting at $179/mo
Troche
Sermorelin Troches
The same growth hormone-releasing peptide as a dissolving troche, for people who would rather skip injections.
30 troches per month
Starting at $209/mo
Injection
CJC-1295 / Ipamorelin
Two peptides that prompt your pituitary to release your own growth hormone, used for deeper sleep, recovery and body composition. Prescribed and dosed by a licensed physician.
Starting at $229/mo
References
- 1.Review of BPC-157 in tissue repair and pain management: mechanisms and the state of the evidence. Int J Mol Sci, 2026
- 2.Review of peptide therapy for tendon, ligament and muscle injury, including BPC-157. Pharmaceuticals (Basel), 2026
- 3.BPC-157 and TB-500 improved Achilles tendon healing on histological and biomechanical measures in a rat model. Jt Dis Relat Surg, 2026
- 4.Thymosin beta-4 (the parent of TB-500): the journey from laboratory to human trials in eye repair. Expert Opin Biol Ther, 2018
- 5.Topically applied GHK-Cu as an anti-aging peptide: advantages, problems and prospects. Bioimpacts, 2025
Prescription products require an online evaluation with a licensed medical professional who will determine if a prescription is appropriate. Products are compounded by a licensed pharmacy. The FDA has not reviewed or approved compounded products for any use for safety, efficacy, or quality. Compounded medications are not FDA-approved brand-name products.